
Global Blood Banking and Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
According to APO Research, The global Blood Banking and Blood Products market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Blood Banking and Blood Products include Red Cross Society of China, Yuanda Shuyang, Weiguang Bio, Tiantan Bio, CBPO, Shuanglin Bio, RAAS, Nanyue Bio and Hualan Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Blood Banking and Blood Products, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Blood Banking and Blood Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Blood Banking and Blood Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Blood Banking and Blood Products revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Blood Banking and Blood Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Blood Banking and Blood Products revenue, projected growth trends, production technology, application and end-user industry.
Blood Banking and Blood Products Segment by Company
Red Cross Society of China
Yuanda Shuyang
Weiguang Bio
Tiantan Bio
CBPO
Shuanglin Bio
RAAS
Nanyue Bio
Hualan Bio
Boya Bio
Vitalant
Takeda
Sanquin Blood Supply Foundation
Octapharma
NHS Blood and Transplant
New York Blood Center
National Blood Transfusion Council
LFB Group
KM Biologics
Kedrion
Japan Red Cross Society
Grifols
CSL
Canadian Blood Services
BPL
Blood Bank of Alaska
Biotest
Australia Red Cross
American Red Cross
America’s Blood Centers
Blood Banking and Blood Products Segment by Type
RBCs
Whole Blood
Plasma
Plasma Fractionation Products
Plts
Blood Banking and Blood Products Segment by Application
Clinic
Hospital
Retail Pharmacy
Others
Blood Banking and Blood Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Banking and Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Banking and Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Banking and Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Blood Banking and Blood Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Banking and Blood Products industry.
Chapter 3: Detailed analysis of Blood Banking and Blood Products companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Banking and Blood Productsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Blood Banking and Blood Products market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Blood Banking and Blood Products include Red Cross Society of China, Yuanda Shuyang, Weiguang Bio, Tiantan Bio, CBPO, Shuanglin Bio, RAAS, Nanyue Bio and Hualan Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Blood Banking and Blood Products, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Blood Banking and Blood Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Blood Banking and Blood Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Blood Banking and Blood Products revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Blood Banking and Blood Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Blood Banking and Blood Products revenue, projected growth trends, production technology, application and end-user industry.
Blood Banking and Blood Products Segment by Company
Red Cross Society of China
Yuanda Shuyang
Weiguang Bio
Tiantan Bio
CBPO
Shuanglin Bio
RAAS
Nanyue Bio
Hualan Bio
Boya Bio
Vitalant
Takeda
Sanquin Blood Supply Foundation
Octapharma
NHS Blood and Transplant
New York Blood Center
National Blood Transfusion Council
LFB Group
KM Biologics
Kedrion
Japan Red Cross Society
Grifols
CSL
Canadian Blood Services
BPL
Blood Bank of Alaska
Biotest
Australia Red Cross
American Red Cross
America’s Blood Centers
Blood Banking and Blood Products Segment by Type
RBCs
Whole Blood
Plasma
Plasma Fractionation Products
Plts
Blood Banking and Blood Products Segment by Application
Clinic
Hospital
Retail Pharmacy
Others
Blood Banking and Blood Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Banking and Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Banking and Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Banking and Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Blood Banking and Blood Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Banking and Blood Products industry.
Chapter 3: Detailed analysis of Blood Banking and Blood Products companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Banking and Blood Productsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
192 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Blood Banking and Blood Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
- 1.2.2 RBCs
- 1.2.3 Whole Blood
- 1.2.4 Plasma
- 1.2.5 Plasma Fractionation Products
- 1.2.6 Plts
- 1.3 Market Analysis by Application
- 1.3.1 Global Blood Banking and Blood Products Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
- 1.3.2 Clinic
- 1.3.3 Hospital
- 1.3.4 Retail Pharmacy
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Blood Banking and Blood Products Growth Trends by Region
- 1.5.1 Global Blood Banking and Blood Products Market Size by Region: 2020 VS 2024 VS 2031
- 1.5.2 Blood Banking and Blood Products Market Size by Region (2020-2025)
- 1.5.3 Blood Banking and Blood Products Market Size by Region (2026-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
- 2 Global Blood Banking and Blood Products Market Dynamics
- 2.1 Blood Banking and Blood Products Industry Trends
- 2.2 Blood Banking and Blood Products Industry Drivers
- 2.3 Blood Banking and Blood Products Industry Opportunities and Challenges
- 2.4 Blood Banking and Blood Products Industry Restraints
- 3 Competitive Landscape by Company
- 3.1 Global Blood Banking and Blood Products Revenue by Company (2020-2025)
- 3.2 Global Blood Banking and Blood Products Players Revenue Ranking, 2023 VS 2024 VS 2025
- 3.3 Global Blood Banking and Blood Products Key Company Head office and Area Served
- 3.4 Global Blood Banking and Blood Products Company, Product Type & Application
- 3.5 Global Blood Banking and Blood Products Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Blood Banking and Blood Products Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Blood Banking and Blood Products Players Market Share by Revenue in 2024
- 3.6.3 2024 Blood Banking and Blood Products Tier 1, Tier 2, and Tier 3
- 4 Blood Banking and Blood Products Market by Type
- 4.1 Global Blood Banking and Blood Products Market Size by Type (2020 VS 2024 VS 2031)
- 4.2 Global Blood Banking and Blood Products Market Size by Type (2020-2031)
- 4.3 Global Blood Banking and Blood Products Market Size Share by Type (2020-2031)
- 5 Blood Banking and Blood Products Market by Application
- 5.1 Global Blood Banking and Blood Products Market Size by Application (2020 VS 2024 VS 2031)
- 5.2 Global Blood Banking and Blood Products Market Size by Application (2020-2031)
- 5.3 Global Blood Banking and Blood Products Market Size Share by Application (2020-2031)
- 6 Company Profiles
- 6.1 Red Cross Society of China
- 6.1.1 Red Cross Society of China Comapny Information
- 6.1.2 Red Cross Society of China Business Overview
- 6.1.3 Red Cross Society of China Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.1.4 Red Cross Society of China Blood Banking and Blood Products Product Portfolio
- 6.1.5 Red Cross Society of China Recent Developments
- 6.2 Yuanda Shuyang
- 6.2.1 Yuanda Shuyang Comapny Information
- 6.2.2 Yuanda Shuyang Business Overview
- 6.2.3 Yuanda Shuyang Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.2.4 Yuanda Shuyang Blood Banking and Blood Products Product Portfolio
- 6.2.5 Yuanda Shuyang Recent Developments
- 6.3 Weiguang Bio
- 6.3.1 Weiguang Bio Comapny Information
- 6.3.2 Weiguang Bio Business Overview
- 6.3.3 Weiguang Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.3.4 Weiguang Bio Blood Banking and Blood Products Product Portfolio
- 6.3.5 Weiguang Bio Recent Developments
- 6.4 Tiantan Bio
- 6.4.1 Tiantan Bio Comapny Information
- 6.4.2 Tiantan Bio Business Overview
- 6.4.3 Tiantan Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.4.4 Tiantan Bio Blood Banking and Blood Products Product Portfolio
- 6.4.5 Tiantan Bio Recent Developments
- 6.5 CBPO
- 6.5.1 CBPO Comapny Information
- 6.5.2 CBPO Business Overview
- 6.5.3 CBPO Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.5.4 CBPO Blood Banking and Blood Products Product Portfolio
- 6.5.5 CBPO Recent Developments
- 6.6 Shuanglin Bio
- 6.6.1 Shuanglin Bio Comapny Information
- 6.6.2 Shuanglin Bio Business Overview
- 6.6.3 Shuanglin Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.6.4 Shuanglin Bio Blood Banking and Blood Products Product Portfolio
- 6.6.5 Shuanglin Bio Recent Developments
- 6.7 RAAS
- 6.7.1 RAAS Comapny Information
- 6.7.2 RAAS Business Overview
- 6.7.3 RAAS Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.7.4 RAAS Blood Banking and Blood Products Product Portfolio
- 6.7.5 RAAS Recent Developments
- 6.8 Nanyue Bio
- 6.8.1 Nanyue Bio Comapny Information
- 6.8.2 Nanyue Bio Business Overview
- 6.8.3 Nanyue Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.8.4 Nanyue Bio Blood Banking and Blood Products Product Portfolio
- 6.8.5 Nanyue Bio Recent Developments
- 6.9 Hualan Bio
- 6.9.1 Hualan Bio Comapny Information
- 6.9.2 Hualan Bio Business Overview
- 6.9.3 Hualan Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.9.4 Hualan Bio Blood Banking and Blood Products Product Portfolio
- 6.9.5 Hualan Bio Recent Developments
- 6.10 Boya Bio
- 6.10.1 Boya Bio Comapny Information
- 6.10.2 Boya Bio Business Overview
- 6.10.3 Boya Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.10.4 Boya Bio Blood Banking and Blood Products Product Portfolio
- 6.10.5 Boya Bio Recent Developments
- 6.11 Vitalant
- 6.11.1 Vitalant Comapny Information
- 6.11.2 Vitalant Business Overview
- 6.11.3 Vitalant Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.11.4 Vitalant Blood Banking and Blood Products Product Portfolio
- 6.11.5 Vitalant Recent Developments
- 6.12 Takeda
- 6.12.1 Takeda Comapny Information
- 6.12.2 Takeda Business Overview
- 6.12.3 Takeda Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.12.4 Takeda Blood Banking and Blood Products Product Portfolio
- 6.12.5 Takeda Recent Developments
- 6.13 Sanquin Blood Supply Foundation
- 6.13.1 Sanquin Blood Supply Foundation Comapny Information
- 6.13.2 Sanquin Blood Supply Foundation Business Overview
- 6.13.3 Sanquin Blood Supply Foundation Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.13.4 Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio
- 6.13.5 Sanquin Blood Supply Foundation Recent Developments
- 6.14 Octapharma
- 6.14.1 Octapharma Comapny Information
- 6.14.2 Octapharma Business Overview
- 6.14.3 Octapharma Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.14.4 Octapharma Blood Banking and Blood Products Product Portfolio
- 6.14.5 Octapharma Recent Developments
- 6.15 NHS Blood and Transplant
- 6.15.1 NHS Blood and Transplant Comapny Information
- 6.15.2 NHS Blood and Transplant Business Overview
- 6.15.3 NHS Blood and Transplant Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.15.4 NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio
- 6.15.5 NHS Blood and Transplant Recent Developments
- 6.16 New York Blood Center
- 6.16.1 New York Blood Center Comapny Information
- 6.16.2 New York Blood Center Business Overview
- 6.16.3 New York Blood Center Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.16.4 New York Blood Center Blood Banking and Blood Products Product Portfolio
- 6.16.5 New York Blood Center Recent Developments
- 6.17 National Blood Transfusion Council
- 6.17.1 National Blood Transfusion Council Comapny Information
- 6.17.2 National Blood Transfusion Council Business Overview
- 6.17.3 National Blood Transfusion Council Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.17.4 National Blood Transfusion Council Blood Banking and Blood Products Product Portfolio
- 6.17.5 National Blood Transfusion Council Recent Developments
- 6.18 LFB Group
- 6.18.1 LFB Group Comapny Information
- 6.18.2 LFB Group Business Overview
- 6.18.3 LFB Group Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.18.4 LFB Group Blood Banking and Blood Products Product Portfolio
- 6.18.5 LFB Group Recent Developments
- 6.19 KM Biologics
- 6.19.1 KM Biologics Comapny Information
- 6.19.2 KM Biologics Business Overview
- 6.19.3 KM Biologics Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.19.4 KM Biologics Blood Banking and Blood Products Product Portfolio
- 6.19.5 KM Biologics Recent Developments
- 6.20 Kedrion
- 6.20.1 Kedrion Comapny Information
- 6.20.2 Kedrion Business Overview
- 6.20.3 Kedrion Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.20.4 Kedrion Blood Banking and Blood Products Product Portfolio
- 6.20.5 Kedrion Recent Developments
- 6.21 Japan Red Cross Society
- 6.21.1 Japan Red Cross Society Comapny Information
- 6.21.2 Japan Red Cross Society Business Overview
- 6.21.3 Japan Red Cross Society Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.21.4 Japan Red Cross Society Blood Banking and Blood Products Product Portfolio
- 6.21.5 Japan Red Cross Society Recent Developments
- 6.22 Grifols
- 6.22.1 Grifols Comapny Information
- 6.22.2 Grifols Business Overview
- 6.22.3 Grifols Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.22.4 Grifols Blood Banking and Blood Products Product Portfolio
- 6.22.5 Grifols Recent Developments
- 6.23 CSL
- 6.23.1 CSL Comapny Information
- 6.23.2 CSL Business Overview
- 6.23.3 CSL Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.23.4 CSL Blood Banking and Blood Products Product Portfolio
- 6.23.5 CSL Recent Developments
- 6.24 Canadian Blood Services
- 6.24.1 Canadian Blood Services Comapny Information
- 6.24.2 Canadian Blood Services Business Overview
- 6.24.3 Canadian Blood Services Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.24.4 Canadian Blood Services Blood Banking and Blood Products Product Portfolio
- 6.24.5 Canadian Blood Services Recent Developments
- 6.25 BPL
- 6.25.1 BPL Comapny Information
- 6.25.2 BPL Business Overview
- 6.25.3 BPL Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.25.4 BPL Blood Banking and Blood Products Product Portfolio
- 6.25.5 BPL Recent Developments
- 6.26 Blood Bank of Alaska
- 6.26.1 Blood Bank of Alaska Comapny Information
- 6.26.2 Blood Bank of Alaska Business Overview
- 6.26.3 Blood Bank of Alaska Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.26.4 Blood Bank of Alaska Blood Banking and Blood Products Product Portfolio
- 6.26.5 Blood Bank of Alaska Recent Developments
- 6.27 Biotest
- 6.27.1 Biotest Comapny Information
- 6.27.2 Biotest Business Overview
- 6.27.3 Biotest Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.27.4 Biotest Blood Banking and Blood Products Product Portfolio
- 6.27.5 Biotest Recent Developments
- 6.28 Australia Red Cross
- 6.28.1 Australia Red Cross Comapny Information
- 6.28.2 Australia Red Cross Business Overview
- 6.28.3 Australia Red Cross Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.28.4 Australia Red Cross Blood Banking and Blood Products Product Portfolio
- 6.28.5 Australia Red Cross Recent Developments
- 6.29 American Red Cross
- 6.29.1 American Red Cross Comapny Information
- 6.29.2 American Red Cross Business Overview
- 6.29.3 American Red Cross Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.29.4 American Red Cross Blood Banking and Blood Products Product Portfolio
- 6.29.5 American Red Cross Recent Developments
- 6.30 America’s Blood Centers
- 6.30.1 America’s Blood Centers Comapny Information
- 6.30.2 America’s Blood Centers Business Overview
- 6.30.3 America’s Blood Centers Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.30.4 America’s Blood Centers Blood Banking and Blood Products Product Portfolio
- 6.30.5 America’s Blood Centers Recent Developments
- 7 North America
- 7.1 North America Blood Banking and Blood Products Market Size (2020-2031)
- 7.2 North America Blood Banking and Blood Products Market Size by Type
- 7.2.1 North America Blood Banking and Blood Products Market Size by Type (2020-2025)
- 7.2.2 North America Blood Banking and Blood Products Market Size by Type (2026-2031)
- 7.2.3 North America Blood Banking and Blood Products Market Share by Type (2020-2031)
- 7.3 North America Blood Banking and Blood Products Market Size by Application
- 7.3.1 North America Blood Banking and Blood Products Market Size by Application (2020-2025)
- 7.3.2 North America Blood Banking and Blood Products Market Size by Application (2026-2031)
- 7.3.3 North America Blood Banking and Blood Products Market Share by Application (2020-2031)
- 7.4 North America Blood Banking and Blood Products Market Size by Country
- 7.4.1 North America Blood Banking and Blood Products Market Size by Country (2020 VS 2024 VS 2031)
- 7.4.2 North America Blood Banking and Blood Products Market Size by Country (2020-2025)
- 7.4.3 North America Blood Banking and Blood Products Market Size by Country (2026-2031)
- 7.4.4 North America Blood Banking and Blood Products Market Share by Country (2020-2031)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
- 8 Europe
- 8.1 Europe Blood Banking and Blood Products Market Size (2020-2031)
- 8.2 Europe Blood Banking and Blood Products Market Size by Type
- 8.2.1 Europe Blood Banking and Blood Products Market Size by Type (2020-2025)
- 8.2.2 Europe Blood Banking and Blood Products Market Size by Type (2026-2031)
- 8.2.3 Europe Blood Banking and Blood Products Market Share by Type (2020-2031)
- 8.3 Europe Blood Banking and Blood Products Market Size by Application
- 8.3.1 Europe Blood Banking and Blood Products Market Size by Application (2020-2025)
- 8.3.2 Europe Blood Banking and Blood Products Market Size by Application (2026-2031)
- 8.3.3 Europe Blood Banking and Blood Products Market Share by Application (2020-2031)
- 8.4 Europe Blood Banking and Blood Products Market Size by Country
- 8.4.1 Europe Blood Banking and Blood Products Market Size by Country (2020 VS 2024 VS 2031)
- 8.4.2 Europe Blood Banking and Blood Products Market Size by Country (2020-2025)
- 8.4.3 Europe Blood Banking and Blood Products Market Size by Country (2026-2031)
- 8.4.4 Europe Blood Banking and Blood Products Market Share by Country (2020-2031)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
- 9 China
- 9.1 China Blood Banking and Blood Products Market Size (2020-2031)
- 9.2 China Blood Banking and Blood Products Market Size by Type
- 9.2.1 China Blood Banking and Blood Products Market Size by Type (2020-2025)
- 9.2.2 China Blood Banking and Blood Products Market Size by Type (2026-2031)
- 9.2.3 China Blood Banking and Blood Products Market Share by Type (2020-2031)
- 9.3 China Blood Banking and Blood Products Market Size by Application
- 9.3.1 China Blood Banking and Blood Products Market Size by Application (2020-2025)
- 9.3.2 China Blood Banking and Blood Products Market Size by Application (2026-2031)
- 9.3.3 China Blood Banking and Blood Products Market Share by Application (2020-2031)
- 10 Asia (Excluding China)
- 10.1 Asia Blood Banking and Blood Products Market Size (2020-2031)
- 10.2 Asia Blood Banking and Blood Products Market Size by Type
- 10.2.1 Asia Blood Banking and Blood Products Market Size by Type (2020-2025)
- 10.2.2 Asia Blood Banking and Blood Products Market Size by Type (2026-2031)
- 10.2.3 Asia Blood Banking and Blood Products Market Share by Type (2020-2031)
- 10.3 Asia Blood Banking and Blood Products Market Size by Application
- 10.3.1 Asia Blood Banking and Blood Products Market Size by Application (2020-2025)
- 10.3.2 Asia Blood Banking and Blood Products Market Size by Application (2026-2031)
- 10.3.3 Asia Blood Banking and Blood Products Market Share by Application (2020-2031)
- 10.4 Asia Blood Banking and Blood Products Market Size by Country
- 10.4.1 Asia Blood Banking and Blood Products Market Size by Country (2020 VS 2024 VS 2031)
- 10.4.2 Asia Blood Banking and Blood Products Market Size by Country (2020-2025)
- 10.4.3 Asia Blood Banking and Blood Products Market Size by Country (2026-2031)
- 10.4.4 Asia Blood Banking and Blood Products Market Share by Country (2020-2031)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
- 11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Blood Banking and Blood Products Market Size (2020-2031)
- 11.2 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Type
- 11.2.1 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Type (2020-2025)
- 11.2.2 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Type (2026-2031)
- 11.2.3 South America, Middle East & Africa Blood Banking and Blood Products Market Share by Type (2020-2031)
- 11.3 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Application
- 11.3.1 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Application (2020-2025)
- 11.3.2 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Application (2026-2031)
- 11.3.3 South America, Middle East & Africa Blood Banking and Blood Products Market Share by Application (2020-2031)
- 11.4 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Country
- 11.4.1 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Country (2020 VS 2024 VS 2031)
- 11.4.2 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Country (2020-2025)
- 11.4.3 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Country (2026-2031)
- 11.4.4 South America, Middle East & Africa Blood Banking and Blood Products Market Share by Country (2020-2031)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
- 12 Concluding Insights
- 13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.